The NSW Government has pledged to expand and operate an advanced, licensed, clinical-grade viral vector manufacturing facility. The facility will be situated in the Westmead Health and Innovation District in western Sydney and will have the production capacity to cater to the growing demand for viral vectors for use in gene therapy research and clinical trials in Australia and internationally.

The NSW Government will commit a total of $134.5 million to establish the Facility and manufacture viral vector products for research and clinical trials.

The project encompasses the building of a commercial-grade viral vector manufacturing facility to service clinical trials (550L from 25L capacity). The facility will be fitted out with specialised equipment, including laboratories, plant rooms, and services, and will be situated within the Kids Research Building and Innovation Centre.

Download Project Summary